This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Acetazolamide

Read time: 1 mins
Marketing start date: 18 Nov 2024

Summary of product characteristics


Effective Time

20221017

Version

3

Spl Product Data Elements

Acetazolamide Acetazolamide ACETAZOLAMIDE SODIUM ACETAZOLAMIDE SODIUM HYDROXIDE HYDROCHLORIC ACID

Application Number

ANDA206533

Brand Name

Acetazolamide

Generic Name

Acetazolamide

Product Ndc

70771-1490

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Container Label NDC 70771-1490-1 AcetaZOLAMIDE for Injection USP 500 mg* per vial For Intravenous Use 1 Single-Dose Vial Rx Only Carton Label NDC 70771-1490-1 AcetaZOLAMIDE for Injection USP 500 mg* per vial For Intravenous Use 1 Single-Dose Vial Rx Only figure02 figure03

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.